Vincent Gualtieri - Sigma Pharmaceuticals Insider

SIP -- Australia Stock  

null 1.31  0.02  1.55%

  Executive
Mr. Vincent Gualtieri is General Manager Wholesale Sales of Sigma Pharmaceuticals Ltd. He commenced with Sigma in 1996. He managed wholesale sales in Victoria and Tasmania for Sigma before moving into the National Sales Manager role five years ago. Prior to joining Sigma Mr. Gualtieri held the roles of Sales Manager and Administration Manager at Myer.
        
61 3 9215 9215  http://www.sigmaco.com.au

Management Efficiency

The company has return on total asset (ROA) of 4.94 % which means that it generated profit of $4.94 on every $100 spent on asset. This is normal as compared to the sector avarege.
The company has accumulated 96.04 M in total debt with debt to equity ratio (D/E) of 0.17 which may suggest the company is not taking enough advantage from borrowing. Sigma Pharmaceuticals Limited has Current Ratio of 1.49 which is within standard range for the sector.

Similar Executives

Showing few of many executives

EXECUTIVE Since

David GallNational Australia Bank Limited
N/A
Sharon CookNational Australia Bank Limited
2017
Amanda HarknessASX Limited
2007
A GallNational Australia Bank Limited
N/A
Matthew LawranceNational Australia Bank Limited
2016
Angela MentisNational Australia Bank Limited
2017
Ashley WarmbrandNational Australia Bank Limited
2015
Andrew HaggerNational Australia Bank Limited
2016
Mathew CooperBapcor Limited
N/A
Mike BairdNational Australia Bank Limited
2017
Nathan ButlerNational Australia Bank Limited
2008
Andrew KnottNational Australia Bank Limited
2015
John SandersGalaxy Resources Limited
2017
Mandie VilleTPG Telecom Limited
2006
Craig MagillBapcor Limited
2015
Piers ShervingtonCochlear Limited
N/A
Paul AlexanderSonic Healthcare Limited
2013
Simon RobertsonGalaxy Resources Limited
2014
Brendan RedmondBapcor Limited
N/A
Alison GoodgerBWX Limited
N/A
Andrew ThorburnNational Australia Bank Limited
2014

Entity Summary

Sigma Pharmaceuticals Limited engages in the wholesale and distribution of pharmaceutical solutions to hospitals and retail pharmacies in Australia. Sigma Pharmaceuticals Limited (SIP) is traded on Australian Securities Exchange in Australia. It is located in Rowville, VIC and employs 14 people.

Sigma Pharmaceuticals Leadership Team

Scott Jones, General Manager of Merchandise and Marketing
Mark Hooper, CEO, Managing Director, Executive Director
Gary Dunne, COO
Christine Bartlett, Independent Non-Executive Director
Raymond Gunston, Non-Executive Director
Richard Church, General Manager - Logistics
David Bayes, Non-Executive Director
Brian Jamieson, Non-Executive Chairman of the Board
Claire Latham, General Manager - Multi Channel
Jackie Pearson, General Manager - Human Resources
Susan Morgan, General Counsel, Company Secretary
Kathryn Spargo, Non-Executive Independent Director
Gary Woodford, Corporate Affairs Manager
Iona MacPherson, CFO
Alan OHara, General Manager - Supply Chain and Transformation
Sam Lawson, General Counsel, Company Secretary
Vincent Gualtieri, General Manager - Wholesale Sales
Jeffrey Sells, CFO
Richard Harris, General Manager of Systems and Information Technology
David Manuel, Non-Executive Director

Stock Performance Indicators

Current Sentiment - SIP

Sigma Pharmaceuticals Investor Sentiment
Most of Macroaxis users are at this time bullish on Sigma Pharmaceuticals Limited. What is your outlook on investing in Sigma Pharmaceuticals Limited? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip
Currently Active Assets on Macroaxis
OTPBF   
Purchased over 70 shares of
few hours ago
Traded for 40.5
VMW   
Purchased a lot of shares of
few hours ago
Traded for 152.04
S   
Purchased over 500 shares of
few hours ago
Traded for 6.01
DD   
Purchased over 30 shares of
few hours ago
Traded for 83.93
MSFT   
Purchased over 20 shares of
few hours ago
Traded for 107.66
Also please take a look at World Market Map. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.